Suppr超能文献

局部用 0.03%比马前列素促进睫毛生长的安全性、有效性和主观体验。

Safety, effectiveness, and subjective experience with topical bimatoprost 0.03% for eyelash growth.

出版信息

Dermatol Surg. 2010 May;36(5):638-49. doi: 10.1111/j.1524-4725.2010.01519.x. Epub 2010 Apr 1.

Abstract

BACKGROUND

Ocularly applied bimatoprost 0.03% is associated with increased eyelash growth.

OBJECTIVE

To assess the safety, efficacy, and subjective experience of using dermal application of bimatoprost 0.03% for the growth of natural eyelashes.

METHODS

Prospective, open-label study of subjects who desired longer, thicker (fuller), and darker natural eyelashes. Bimatoprost was applied to the upper lid margin once daily for 12 weeks. Adverse events and intraocular pressure were assessed, and subjects completed health outcomes questionnaires. Eyelash growth and darkening were scored using photographs taken at weeks 1 and 12.

RESULTS

All subjects were female (N=28). No serious or unexpected adverse events were reported. The mean change from baseline intraocular pressure was less than 1 mmHg at each time point, but was statistically significant at weeks 1 and 4 (p< or =.047). At week 12, all subjects had noticed significant growth or darkening. Post hoc analysis of photographs corroborated these reports (p<.001).

CONCLUSION

Bimatoprost was found safe for eyelid application and was associated with enhanced eyelash growth. All subjects noticed favorable changes in the appearance of their eyelashes.

摘要

背景

眼部应用 0.03%比马前列素与睫毛增长有关。

目的

评估 0.03%比马前列素经皮给药用于自然睫毛生长的安全性、有效性和主观体验。

方法

对渴望拥有更长、更浓密(更饱满)和更黑的自然睫毛的受试者进行前瞻性、开放性标签研究。比马前列素每天一次涂抹在上眼睑边缘,持续 12 周。评估不良事件和眼压,并让受试者完成健康结果问卷。在第 1 周和第 12 周拍摄照片,对睫毛生长和变深进行评分。

结果

所有受试者均为女性(N=28)。未报告严重或意外的不良事件。每次测量的平均眼压从基线开始的变化均小于 1mmHg,但在第 1 周和第 4 周时具有统计学意义(p<或=.047)。在第 12 周,所有受试者均注意到睫毛有明显的增长或变深。照片的事后分析证实了这些报告(p<.001)。

结论

比马前列素经皮给药安全,与睫毛增长有关。所有受试者都注意到他们的睫毛外观有了明显的改善。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验